Page 1145 - Williams Hematology ( PDFDrive )
P. 1145

1120           Part VIII:  Monocytes and Macrophages




                 243. Henter JI, Samuelsson-Horne A, Arico M, et al: Treatment of hemophagocytic lympho-    249. Horne A, Janka G, Maarten ER, et al: Haematopoietic stem cell transplantation in hae-
                  histiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.   mophagocytic lymphohistiocytosis. Br J Haematol 129:622–630, 2005.
                  Blood 100:2367–2373, 2002.                            250. Cooper N, Rao K, Goulden N, et al: The use of reduced-intensity stem cell transplanta-
                 244. Imashuku S: Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocy-  tion in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis. Bone
                  tosis (EBV-HLH); update 2010. J Pediatr Hematol Oncol 33:35–39, 2011.  Marrow Transplant 42 Suppl 2:S47–S50, 2008.
                 245. Johnson TS, Terrell CE, Millen SH, et al: Etoposide selectively ablates activated T cells     251. Marsh RA, Kim MO, Liu C, et al: An intermediate alemtuzumab schedule reduces the
                  to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis.  J   incidence of mixed chimerism following reduced-intensity conditioning hematopoi-
                  Immunol 192:84–91, 2014.                               etic cell transplantation for hemophagocytic lymphohistiocytosis. Biol Blood Marrow
                 246. Thompson PA, Allen CE, Horton T, et al: Severe neurologic side effects in patients being   Transplant 19:1625–1631, 2013.
                  treated for hemophagocytic lymphohistiocytosis.  Pediatr Blood Cancer 52:621–625,     252. Grom AA, Mellins ED: Macrophage activation syndrome: Advances towards under-
                  2009.                                                  standing pathogenesis. Curr Opin Rheumatol 22:561–566, 2010.
                 247. Mahlaoui N,  Ouachee-Chardin M,  de Saint  BG,  et al:  Immunotherapy of  familial     253. Schulert GS, Grom AA: Macrophage activation syndrome and cytokine-directed ther-
                  hemophagocytic lymphohistiocytosis with antithymocyte globulins: A single-center   apies. Best Pract Res Clin Rheumatol 28:277–292, 2014.
                  retrospective report of 38 patients. Pediatrics 120:e622–e628, 2007.    254. Lau SK, Chu PG, Weiss LM: Immunohistochemical expression of Langerin in Langer-
                 248. Marsh RA, Allen CE, McClain KL, et al: Salvage therapy of refractory hemophagocytic   hans cell histiocytosis and non-Langerhans cell histiocytic disorders. Am J Surg Pathol
                  lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer 60:101–109, 2013.  32:615–619, 2008.











































































          Kaushansky_chapter 71_p1101-1120.indd   1120                                                                  9/17/15   3:51 PM
   1140   1141   1142   1143   1144   1145   1146   1147   1148   1149   1150